• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Xetra	116,600	10.07.24 09:04:21	+1,000	+0,87%	116,000	116,600	116,600	115,600
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	84,500	10.07.24 08:44:08	+4,500	+5,62%	84,000	85,500	84,500	80,000